Valuation Photocure ASA

Stocks

Market Closed - Oslo Bors 15:45:00 20/10/2026 BST			5-day change	1st Jan Change
50.10 ^NOK	+0.30%		+1.21%	-29.83%

08-16	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems	MT
08-14	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,769	2,895	1,827	1,681	1,900	1,349	-	-
Change	-	4.55%	-36.89%	-8.01%	13.04%	-29.01%	-	-
Enterprise Value (EV) ¹	2,483	2,639	1,567	1,387	1,661	1,180	1,192	1,189
Change	-	6.28%	-40.61%	-11.53%	19.77%	-28.98%	1.02%	-0.22%
P/E	-89.3x	-40.2x	6,740x	-344x	-1,190x	17.7x	64.2x	43.2x
PBR	-	-	-	-	-	3.75x	3.44x	3.24x
PEG	-	-0x	-67x	0x	17.9x	-0x	-0.9x	0.9x
Capitalization / Revenue	7.68x	7.73x	4.09x	3.42x	3.57x	2.05x	2.02x	1.87x
EV / Revenue	6.89x	7.05x	3.51x	2.82x	3.12x	1.79x	1.79x	1.65x
EV / EBITDA	136x	-107x	28.2x	28.2x	57.8x	7.73x	12.5x	13.7x
EV / EBIT	-426x	-53.9x	56.4x	68x	-2,229x	10.7x	28.1x	21.7x
EV / FCF	113x	-469x	35.4x	18.4x	95x	17.9x	105x	48.9x
FCF Yield	0.89%	-0.21%	2.82%	5.43%	1.05%	5.6%	0.95%	2.05%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.15	-2.66	0.01	-0.18	-0.06	2.83	0.78	1.16
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	360.5	374.5	446.2	491.7	532.6	658.3	666.3	720.3
EBITDA ¹	18.3	-24.63	55.49	49.19	28.73	152.5	95	86.5
EBIT ¹	-5.826	-49	27.81	20.4	-0.745	110.3	42.33	54.67
Net income ¹	-30.9	-71.86	0.267	-4.81	-1.519	76.33	21	31.67
Net Debt ¹	-285.4	-255.6	-259.5	-293.9	-238.9	-169	-157	-159.7
Reference price ²	102.70	106.80	67.40	62.00	71.40	50.10	50.10	50.10
Nbr of stocks (in thousands)	26,960	27,106	27,106	27,106	26,607	26,917	-	-
Announcement Date	23/02/22	23/02/23	21/02/24	19/02/25	18/02/26	-	-	-

¹NOK in Million²NOK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PHOTOCURE ASA	17.65x	1.79x	7.71x	-	143M
ELI LILLY AND COMPANY	35.75x	12.79x	26.94x	0.55%	1,106B
JOHNSON & JOHNSON	37.14x	6.26x	17.62x	2.1%	612B
ABBVIE INC.	36.08x	8.31x	17.14x	2.43%	500B
ROCHE HOLDING AG	20.6x	4.98x	12.38x	2.63%	367B
MERCK & CO., INC.	104.7x	5.86x	25.15x	2.37%	354B
NOVARTIS AG	21.05x	5.51x	13.55x	2.9%	286B
ASTRAZENECA PLC	21.56x	4.37x	12.5x	2.02%	256B
AMGEN INC.	26.98x	6.96x	12.46x	2.37%	230B
GILEAD SCIENCES, INC.	-44.72x	6.87x	26.59x	2.15%	190B
Average	27.68x	6.37x	17.20x	2.17%	390.03B
Weighted average by Cap.	34.40x	8.11x	19.89x	1.85%